SICAV Funds performance table

help icon
fund name 1 mthsort icon 3 mth 12 mth ytd Inception Net assets Return Date
Duemme SICAV US Eq I Acc 8% 1% 0% 14% 16% 27M 2012-07-31
UBP MultiFunds II Russian Equity B 8% -5% -26% 8% 7% - 2012-01-31
New Millennium Augustum Pan Europ Eq I 8% 17% -12% 20% 1% 1M 2012-02-29
ING (L) Invest Glbl Real Estate I€ Acc 8% 9% 19% 24% 4% 293M 2014-10-31
BGF Global Equity X2 USD 8% 0% -7% 8% 1% 286M 2012-01-31
Bellevue(Lux) BB Medtech I EUR 8% 13% 28% 25% 15% 136M 2014-10-31
Eastspring Inv Japan Equity D 8% 6% 35% 24% 0% 173M 2013-09-30
BGF US Small & MidCap Opps X2 USD 8% 10% 11% 8% 11% 360M 2013-01-31
Bellevue(Lux) BB Medtech I CHF 8% 12% 26% 23% 10% 164M 2014-10-31
Structura LDI Index Linked Plus (GBP) IG 8% 15% 0% 0% 18% - 2011-11-30
RBC Fds (Lux) US Small Cap Equity O Acc 8% 6% 7% 3% 17% 18M 2014-10-31
Alken European Opportunities Z1 8% 2% 7% 16% 6% 1956M 2012-07-31
UBS (Lux) SS RICI (CHF) I-62 Acc 8% 13% 11% 0% 11% 76M 2010-09-30
Parvest Equity Indonesia P C 8% 7% -16% 0% -8% 124M 2014-07-31
Parvest Equity Indonesia P D 8% 7% 0% 32% -3% 124M 2014-07-31
db x-trackers Stoxx Eurp600 Oil&Gas SD1C 8% 7% -2% -1% -7% 4M 2014-10-31
Pictet Biotech-HI EUR 8% 15% 32% 20% 9% 1195M 2014-10-31
Pictet Biotech-I USD 8% 15% 32% 20% 7% 1498M 2014-10-31
Franklin Biotechnology Disc I Acc $ 8% 19% 45% 31% 15% 2580M 2014-10-31
Nordea-1 Brazilian Equity BI GBP 8% 12% 15% 14% 1% 7M 2014-08-31
Franklin Biotechnology Disc I Acc €-H1 8% 19% 46% 32% 51% 2060M 2014-10-31
Blue Danube Futures Sel Inc 8% 9% -6% -5% 0% 2M 2011-09-30
Blue Danube Futures Sel Acc 8% 9% -6% -5% 0% 2M 2011-09-30
BGF Emerging Markets X2 8% 0% -7% 8% 3% 1166M 2012-01-31
WestLB Me Co Fd Euro Eq rf-A 8% -10% -9% -9% -1% 0M 2011-10-31
Nordea-1 Global Real Estate BI SEK 8% 7% 25% 28% 17% 1180M 2014-10-31
AXA WF Frm Global Real Est Sec M-C EUR 8% 8% 0% 22% 23% 108M 2014-10-31
BNPP L1 Equity Europe Consumer Dur I 8% 9% 36% 13% 14% 7M 2013-05-31
AA MMF EII Global Property I Eur 7% 6% 14% 19% 8% 0M 2014-10-31
AXA WF Frm Global Real Est Sec I-C EUR 7% 8% 17% 21% 17% 108M 2014-10-31

All our data is licensed from Morningstar UK Ltd. Important legal information